Top compounds associated with response to EIF2S3


Feature Type Standardized
Nominal ANOVA
mRNA Nilotinib GDSC1000 pan-cancer AAC 0.073 0.06
mRNA clofarabine CTRPv2 pan-cancer AAC 0.057 0.06
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.069 0.06
mRNA lovastatin CTRPv2 pan-cancer AAC 0.072 0.06
mRNA UNC0638 GDSC1000 pan-cancer AAC -0.058 0.06
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.061 0.06
mRNA tacedinaline CTRPv2 pan-cancer AAC -0.075 0.06
mRNA StemRegenin 1 CTRPv2 pan-cancer AAC 0.068 0.06
mRNA SN-38 GDSC1000 pan-cancer AAC 0.064 0.06
mRNA BMS-754807 CTRPv2 pan-cancer AAC -0.066 0.07
Download CSV